{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:23:33Z","timestamp":1789439013919,"version":"build-2803163510"},"reference-count":134,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001501","name":"(DSKPDF) scheme by University Grants Commission","doi-asserted-by":"publisher","award":["F.4-2\/2006 (BSR)\/BL\/19-20\/0018"],"award-info":[{"award-number":["F.4-2\/2006 (BSR)\/BL\/19-20\/0018"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RAIAD"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Anti-inflammatory therapies currently in use mainly include steroidal and non-steroidal\ndrugs. Contrary to their side effects, the steroid hormones glucocorticoids, which are synthetic\nversions of natural cortisol, are nevertheless often employed to treat a variety of inflammatory\ndisorders. Other drug class of choice is non-steroidal drugs which mainly target COX-2 and hence\nthe synthesis of prostaglandins, particularly PGE2. To cure both the short-term effects of chronic\ninflammatory disorders and the long-term symptoms of acute inflammation, pharmaceutical\nchemists are in continuous search for more potent and less toxic agents. Apart from these two\ndrug classes, phytochemicals are gaining the attention of researchers as source of alternative antiinflammatory\nagents. However, every drug class has its own advantages or disadvantages thus\nrequiring intervention of newer approaches. Currently, drugs used for anti-inflammatory therapies\nare costly with low efficacy, high health risk, and socio-economic impact due to the concern issue\nof their toxicity. Recently, nano-drug delivery system has been experiencing main interest as a\nnew approach for targeting therapeutic agents to the target sites in a controlled, sustained manner\nand has various advantages as compared to the conventional drug delivery system like, increased\nsolubility, bioavailability, improved pharmacokinetic profile of drugs, surface area and rate of\ndissolution and additionally, overcomes the problems related to hydrophobicity, toxicity. Present\nreview summarized the intervention of nanotechnology to overcome the limitations\/ risk associated\nwith current anti-inflammatory drugs of different classes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2772270817666221027154402","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T07:22:33Z","timestamp":1666941753000},"page":"7-19","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-Inflammatory Therapeutics: Conventional Concepts and Future with\nNanotechnology"],"prefix":"10.2174","volume":"17","author":[{"given":"Pawan","family":"Kaur","sequence":"first","affiliation":[{"name":"Skill-Faculty of\nAgriculture, Shri Vishwakarma Skill University, Gurugram-122004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Bernela","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Guru Nanak Dev University, Amritsar-143001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Kaushal","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Guru Nanak Dev University, Amritsar-143001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Guru Nanak Dev University, Amritsar-143001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Bio and Nanotechnology,\nGuru Jambheshwar University of Science and Technology, Hisar-125001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical\nSciences, Guru Jambheshwar University of Science and Technology, Hisar-125001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/pharmaceutics13010064","volume":"13","author":"Placha D.","year":"2021","unstructured":"Placha D.; Jampilek J.; Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics 2021,13(1),64","journal-title":"Pharmaceutics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph8020151","volume":"8","author":"Oyinloye B.","year":"2015","unstructured":"Oyinloye B.; Adenowo A.; Kappo A.; Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases. Pharmaceuticals (Basel) 2015,8(2),151-175","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41398-021-01198-w","volume":"11","author":"Han V.X.","year":"2021","unstructured":"Han V.X.; Patel S.; Jones H.F.; Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: A systematic review. Transl Psychiatry 2021,11(1),71","journal-title":"Transl Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"Koushki K.","year":"2021","unstructured":"Koushki K.; Shahbaz S.K.; Mashayekhi K.; Anti-inflammatory action of statins in cardiovascular disease: The role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol 2021,60(2),175-199","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/all.13844","volume":"74","author":"Do\u00f1a I.","year":"2019","unstructured":"Do\u00f1a I.; Jurado-Escobar R.; Perkins J.R.; Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria. Allergy 2019,74(6),1135-1144","journal-title":"Allergy"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2217\/nnm-2020-0064","volume":"15","year":"2020","unstructured":"Calpena AC, Soriano JL, G\u00e1lvez P, Clares B. Anti-inflammatory nanomedicines: What does the future hold? Nanomedicine (Lond) B S\u00e1nchez A2020,15(14),1357-1360","journal-title":"Nanomedicine (Lond)"},{"key":"ref=7","first-page":"372","author":"Machado G.C.","year":"2021","unstructured":"Machado G.C.; Abdel-Shaheed C.; Underwood M.; Day R.O.; Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ 2021,372","journal-title":"BMJ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.3390\/ijms20184367","volume":"20","author":"Patil K.R.","year":"2019","unstructured":"Patil K.R.; Mahajan U.B.; Unger B.S.; Animal models of inflammation for screening of anti-inflammatory drugs: Implications for the discovery and development of phytopharmaceuticals. Int J Mol Sci 2019,20(18),4367","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2217\/nnm.12.87","volume":"7","author":"Bamrungsap S.","year":"2012","unstructured":"Bamrungsap S.; Zhao Z.; Chen T.; Nanotechnology in therapeutics: A focus on nanoparticles as a drug delivery system. Nanomedicine (Lond) 2012,7(8),1253-1271","journal-title":"Nanomedicine (Lond)"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4103\/0973-8398.150031","volume":"9","author":"Singh D.","year":"2015","unstructured":"Singh D.; Application of novel drug delivery system in enhancing the therapeutic potential of phytoconstituents. Asian J Pharm 2015,9(4),S1-S12","journal-title":"Asian J Pharm"},{"key":"ref=11","first-page":"185","author":"Pathak Y.","year":"2007","unstructured":"Pathak Y.; Thassu D.; Deleers M.;  Pharmaceutical applications of nanoparticulate drug-delivery systems Nanopart Drug Deliv Syst 2007,185-212","journal-title":"Pharmaceutical applications of nanoparticulate drug-delivery systems Nanopart Drug Deliv Syst"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"Rizvi S.A.A.","year":"2018","unstructured":"Rizvi S.A.A.; Saleh A.M.; Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 2018,26(1),64-70","journal-title":"Saudi Pharm J"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1201\/9781420008449.ch1","author":"Thassu D.","year":"2007","unstructured":"Thassu D.; Pathak Y.; Deleers M.; Nanoparticulate drug-delivery\nsystems: An overview. CRC Press, Boca Raton, 2007"},{"key":"ref=14","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-41129-3","author":"Bhatia S.","year":"2016","unstructured":"Bhatia S.;  Natural polymer drug delivery systems: Nanoparticles, plants, and algae 2016","journal-title":"Natural polymer drug delivery systems: Nanoparticles, plants, and algae"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5606\/ehc.2021.80360","volume":"32","author":"G\u00fcven E.","year":"2021","unstructured":"G\u00fcven E.; Nanotechnology-based drug delivery systems in orthopedics. Eklem Hastalik Cerrahisi 2021,32(1),267-273","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"101961","DOI":"10.1016\/j.jddst.2020.101961","volume":"60","author":"Aminu N.","year":"2020","unstructured":"Aminu N.; Bello I.; Umar N.M.; Tanko N.; Aminu A.; Audu M.M.; The influence of nanoparticulate drug delivery systems in drug therapy. J Drug Deliv Sci Technol 2020,60,101961","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ijms22010138","volume":"22","author":"Kumar A.","year":"2020","unstructured":"Kumar A.; Zhou L.; Zhi K.; Challenges in biomaterial-based drug delivery approach for the treatment of neurodegenerative diseases: Opportunities for extracellular vesicles. Int J Mol Sci 2020,22(1),138","journal-title":"Int J Mol Sci"},{"key":"ref=18","author":"Penta S.","year":"2015","unstructured":"Penta S.;  Advances in structure and activity relationship of coumarin derivatives 2015","journal-title":"Advances in structure and activity relationship of coumarin derivatives"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"Furman D.","year":"2019","unstructured":"Furman D.; Campisi J.; Verdin E.; Chronic inflammation in the etiology of disease across the life span. Nat Med 2019,25(12),1822-1832","journal-title":"Nat Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"Zhao H.","year":"2021","unstructured":"Zhao H.; Wu L.; Yan G.; Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduct Target Ther 2021,6(1),263","journal-title":"Signal Transduct Target Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14202\/vetworld.2018.627-635","volume":"11","author":"Abdulkhaleq L.A.","year":"2018","unstructured":"Abdulkhaleq L.A.; Assi M.A.; Abdullah R.; Zamri-Saad M.; Taufiq-Yap Y.H.; Hezmee M.N.M.; The crucial roles of inflammatory mediators in inflammation: A review. Vet World 2018,11(5),627-635","journal-title":"Vet World"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"100694","DOI":"10.1016\/j.blre.2020.100694","volume":"45","author":"Lordan R.","year":"2021","unstructured":"Lordan R.; Tsoupras A.; Zabetakis I.; Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents. Blood Rev 2021,45,100694","journal-title":"Blood Rev"},{"key":"ref=23","author":"Jain P.","year":"2015","unstructured":"Jain P.; Pandey R.; Shukla S.S.;  Inflammation: Natural resources and its applications 2015","journal-title":"Inflammation: Natural resources and its applications"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"Kennedy B.K.","year":"2014","unstructured":"Kennedy B.K.; Berger S.L.; Brunet A.; Geroscience: Linking aging to chronic disease. Cell 2014,159(4),709-713","journal-title":"Cell"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jot.2017.05.007","volume":"10","author":"Gallo J.","year":"2017","unstructured":"Gallo J.; Raska M.; Kriegova E.; Goodman S.B.; Inflammation and its resolution and the musculoskeletal system. J Orthop Translat 2017,10,52-67","journal-title":"J Orthop Translat"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.2174\/092986712800784676","volume":"19","author":"Clares B.","year":"2012","unstructured":"Clares B.; Ruiz M.A.; Gallardo V.; Arias J.L.; Drug delivery to inflammation based on nanoparticles surface decorated with biomolecules. Curr Med Chem 2012,19(19),3203-3211","journal-title":"Curr Med Chem"},{"key":"ref=27","author":"Penta S.","year":"2015","unstructured":"Penta S.;  Advances in structure and activity relationship of coumarin derivatives 2015","journal-title":"Advances in structure and activity relationship of coumarin derivatives"},{"key":"ref=28","author":"Yasir M.","year":"2022","unstructured":"Yasir M.; Goyal A.; Bansal P.; Sonthalia S.;  Corticosteroid adverse effects 2022","journal-title":"Corticosteroid adverse effects"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"Vane J.R.","year":"2003","unstructured":"Vane J.R.; Botting R.M.; The mechanism of action of aspirin. Thromb Res 2003,110(5-6),255-258","journal-title":"Thromb Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"Vane J.R.","year":"1998","unstructured":"Vane J.R.; Bakhle Y.S.; Botting R.M.; Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998,38(1),97-120","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","volume":"36","author":"Ornelas A.","year":"2017","unstructured":"Ornelas A.; Zacharias-Millward N.; Menter D.G.; Beyond COX-1: The effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev 2017,36(2),289-303","journal-title":"Cancer Metastasis Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"Alfonso L.","year":"2014","unstructured":"Alfonso L.; Ai G.; Spitale R.C.; Bhat G.J.; Molecular targets of aspirin and cancer prevention. Br J Cancer 2014,111(1),61-67","journal-title":"Br J Cancer"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2011.12.018","volume":"678","author":"Li F.","year":"2012","unstructured":"Li F.; Liu S.; Ouyang Y.; Effect of celecoxib on proliferation, collagen expression, ERK1\/2 and SMAD2\/3 phosphorylation in NIH\/3T3 fibroblasts. Eur J Pharmacol 2012,678(1-3),1-5","journal-title":"Eur J Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-03-4063","volume":"64","author":"Zhu J.","year":"2004","unstructured":"Zhu J.; Huang J.W.; Tseng P.H.; From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res 2004,64(12),4309-4318","journal-title":"Cancer Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"Weber A.","year":"2004","unstructured":"Weber A.; Casini A.; Heine A.; Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition. J Med Chem 2004,47(3),550-557","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1016\/j.bmc.2007.08.037","volume":"15","author":"Nishimori I.","year":"2007","unstructured":"Nishimori I.; Minakuchi T.; Onishi S.; Carbonic anhydrase inhibitors: Cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem 2007,15(23),7229-7236","journal-title":"Bioorg Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/head.12769","volume":"56","author":"Lucas S.","year":"2016","unstructured":"Lucas S.; The pharmacology of indomethacin. Headache 2016,56(2),436-446","journal-title":"Headache"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"Ricciotti E.","year":"2011","unstructured":"Ricciotti E.; FitzGerald G.A.; Prostaglandins and Inflammation. Arterioscler Thromb Vasc Biol 2011,31(5),986-1000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=39","author":"Brutzkus J.C.","year":"2021","unstructured":"Brutzkus J.C.; Shahrokhi M.; Varacallo M.;  In: Stat Pearls 2021","journal-title":"In: Stat Pearls"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/j.1875-9114.1986.tb03459.x","volume":"6","author":"Kantor T.G.","year":"1986","unstructured":"Kantor T.G.; Kantor M.D.; Ketoprofen: A review of its pharmacologic and clinical properties. Pharmacotherapy 1986,6(3),93-102","journal-title":"Pharmacotherapy"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/acm.2009.0267","volume":"16","author":"Liao H.L.","year":"2010","unstructured":"Liao H.L.; Ma T.C.; Li Y.C.; Chen J.T.; Chang Y.S.; Concurrent use of corticosteroids with licorice-containing TCM preparations in Taiwan: A National Health Insurance Database study. J Altern Complement Med 2010,16(5),539-544","journal-title":"J Altern Complement Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/17425247.2020.1813107","volume":"17","author":"Ramos Campos E.V.","year":"2020","unstructured":"Ramos Campos E.V.; Proen\u00e7a P.L.D.F.; Doretto-Silva L.; Andrade-Oliveira V.; Fraceto L.F.; de Araujo D.R.; Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv 2020,17(11),1615-1630","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpb.2020.03.020","volume":"151","author":"Leonard F.","year":"2020","unstructured":"Leonard F.; Srinivasan S.; Liu X.; Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. Eur J Pharm Biopharm 2020,151,61-72","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/app11010438","volume":"11","author":"Nedelcu A.","year":"2021","unstructured":"Nedelcu A.; Mosteanu O.; Pop T.; Mocan T.; Mocan L.; Recent advances in nanoparticle-mediated treatment of inflammatory bowel diseases. Appl Sci (Basel) 2021,11(1),438","journal-title":"Appl Sci (Basel)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2019.01.015","volume":"296","author":"Lorscheider M","year":"2019","unstructured":"Lorscheider M; Tsapis N; ur-Rehman M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release 2019,296,179-189","journal-title":"J Control Release"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.nano.2020.102301","volume":"30","author":"Lee H.","year":"2020","unstructured":"Lee H.; Jeong S.W.; Jung E.; Lee D.; Dexamethasone-loaded H2O2-activatable anti-inflammatory nanoparticles for on-demand therapy of inflammatory respiratory diseases. Nanomedicine 2020,30,102301","journal-title":"Nanomedicine"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7324\/JAPS.2020.104003","volume":"10","author":"Acharya S.","year":"2020","unstructured":"Acharya S.; Guru B.R.; Prednisolone encapsulated PLGA nanoparticles: Characterization, cytotoxicity, and anti-inflammatory activity on C6 glial cells. J Appl Pharm Sci 2020,10(4),14-21","journal-title":"J Appl Pharm Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.34172\/PS.2020.94","volume":"27","author":"Acharya S.","year":"2020","unstructured":"Acharya S.; Praveena J.; Guru B.R.; In vitro studies of prednisolone loaded PLGA nanoparticles-surface functionalized with folic acid on glioma and macrophage Cell lines. Ulum-i Daruyi 2020,27(3),407-417","journal-title":"Ulum-i Daruyi"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1208\/s12249-018-1034-z","volume":"19","author":"Gai X.","year":"2018","unstructured":"Gai X.; Jiang Z.; Liu M.; Therapeutic effect of a novel Nano-drug delivery system on membranous glomerulonephritis rat model induced by cationic bovine serum. AAPS PharmSciTech 2018,19(5),2195-2202","journal-title":"AAPS PharmSciTech"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/OAEM.S22795","volume":"3","author":"Hunter L.","year":"2011","unstructured":"Hunter L.; Wood D.; Dargan P.I.; The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose. Open Access Emerg Med 2011,3,39-48","journal-title":"Open Access Emerg Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"503306","DOI":"10.1016\/j.mrgentox.2020.503306","volume":"861-862","author":"Guma A.","year":"2021","unstructured":"Guma A.; Akhtar S.; Najafzadeh M.; Isreb M.; Baumgartner A.; Anderson D.; Ex vivo\/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals. Mutat Res Genet Toxicol Environ Mutagen 2021,861-862,503306","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejpb.2019.02.008","volume":"137","author":"Crivelli B.","year":"2019","unstructured":"Crivelli B.; Bari E.; Perteghella S.; Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. Eur J Pharm Biopharm 2019,137,37-45","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"111042","DOI":"10.1016\/j.msec.2020.111042","volume":"114","author":"Choi J.S.","year":"2020","unstructured":"Choi J.S.; Lee D.H.; Ahn J.B.; Therapeutic effects of celecoxib polymeric systems in rat models of inflammation and adjuvant-induced rheumatoid arthritis. Mater Sci Eng C 2020,114,111042","journal-title":"Mater Sci Eng C"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"119378","DOI":"10.1016\/j.ijpharm.2020.119378","volume":"583","author":"El-Gogary R.I.","year":"2020","unstructured":"El-Gogary R.I.; Khattab M.A.; Abd-Allah H.; Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model. Int J Pharm 2020,583,119378","journal-title":"Int J Pharm"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"111103","DOI":"10.1016\/j.msec.2020.111103","volume":"116","author":"Mishra R.K.","year":"2020","unstructured":"Mishra R.K.; Ahmad A.; Kumar A.; Vyawahare A.; Raza S.S.; Khan R.; Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. Mater Sci Eng C 2020,116,111103","journal-title":"Mater Sci Eng C"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/pharmaceutics13020290","volume":"13","author":"Pontes-Quero G.M.","year":"2021","unstructured":"Pontes-Quero G.M.; Benito-Garz\u00f3n L.; P\u00e9rez Cano J.; Aguilar M.R.; V\u00e1zquez-Lasa B.; Modulation of inflammatory mediators by polymeric nanoparticles loaded with anti-inflammatory drugs. Pharmaceutics 2021,13(2),290","journal-title":"Pharmaceutics"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10787-020-00776-6","volume":"29","author":"Abdollahi A.R.","year":"2021","unstructured":"Abdollahi A.R.; Firouzian F.; Haddadi R.; Nourian A.; Indomethacin loaded dextran stearate polymeric micelles improve adjuvant-induced arthritis in rats: Design and in vivo evaluation. Inflammopharmacology 2021,29(1),107-121","journal-title":"Inflammopharmacology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4103\/1673-5374.295339","volume":"16","author":"Quines C.B.","year":"2021","unstructured":"Quines C.B.; Pinton S.; Gutierrez M.E.Z.; Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice. Neural Regen Res 2021,16(4),783-789","journal-title":"Neural Regen Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"116678","DOI":"10.1016\/j.molliq.2021.116678","volume":"339","author":"Cao Y.","year":"2021","unstructured":"Cao Y.; Khan A.; Ghorbani F.; Predicting adsorption behavior and anti-inflammatory activity of naproxen interacting with pure boron nitride and boron phosphide fullerene-like cages. J Mol Liq 2021,339,116678","journal-title":"J Mol Liq"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/pharmaceutics12080723","volume":"12","author":"Espinosa-Cano E.","year":"2020","unstructured":"Espinosa-Cano E.; Aguilar M.R.; Portilla Y.; Barber D.F.; San Rom\u00e1n J.; Anti-inflammatory polymeric nanoparticles based on ketoprofen and dexamethasone. Pharmaceutics 2020,12(8),723","journal-title":"Pharmaceutics"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","volume":"280","author":"Eisenberg D.M.","year":"1998","unstructured":"Eisenberg D.M.; Davis R.B.; Ettner S.L.; Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998,280(18),1569-1575","journal-title":"JAMA"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9343(98)00416-1","volume":"106","author":"Bent S.","year":"1999","unstructured":"Bent S.; Avins A.L.; An herb for every illness? Am J Med 1999,106(2),259-260","journal-title":"Am J Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S1368980000000525","volume":"3","author":"Tyler V.E.","year":"2000","unstructured":"Tyler V.E.; Herbal medicine: From the past to the future. Public Health Nutr 2000,3(4a),447-452","journal-title":"Public Health Nutr"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1021\/acs.jafc.6b02763","volume":"64","author":"Panyod S.","year":"2016","unstructured":"Panyod S.; Wu W.K.; Ho C.T.; Diet supplementation with allicin protects against alcoholic fatty liver disease in mice by improving anti-inflammation and antioxidative functions. J Agric Food Chem 2016,64(38),7104-7113","journal-title":"J Agric Food Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuint.2014.01.015","volume":"68","author":"Chen W.","year":"2014","unstructured":"Chen W.; Qi J.; Feng F.; Neuroprotective effect of allicin against traumatic brain injury via Akt\/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities. Neurochem Int 2014,68,28-37","journal-title":"Neurochem Int"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"103306","DOI":"10.1016\/j.etap.2019.103306","volume":"74","author":"Orabi S.H.","year":"2020","unstructured":"Orabi S.H.; Abd Eldaium D.; Hassan A.; Sabagh H.S.E.; Abd Eldaim M.A.; Allicin modulates diclofenac sodium induced hepatonephro toxicity in rats via reducing oxidative stress and caspase 3 protein expression. Environ Toxicol Pharmacol 2020,74,103306","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e22470","DOI":"10.1002\/jbt.22470","volume":"34","author":"Samra Y.A.","year":"2020","unstructured":"Samra Y.A.; Hamed M.F.; El-Sheakh A.R.; Hepatoprotective effect of allicin against acetaminophen\u2010induced liver injury: Role of inflammasome pathway, apoptosis, and liver regeneration. J Biochem Mol Toxicol 2020,34(5),e22470","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"39625","DOI":"10.1007\/s11356-021-13392-w","volume":"28","author":"Sun D.","year":"2021","unstructured":"Sun D.; Sun C.; Qiu G.; Allicin mitigates hepatic injury following cyclophosphamide administration via activation of Nrf2\/ARE pathways and through inhibition of inflammatory and apoptotic machinery. Environ Sci Pollut Res Int 2021,28(29),39625-39636","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"58768","DOI":"10.1007\/s11356-021-14800-x","volume":"28","author":"Edres H.A.","year":"2021","unstructured":"Edres H.A.; Taha N.M.; Lebda M.A.; Elfeky M.S.; The potential neuroprotective effect of allicin and melatonin in acrylamide-induced brain damage in rats. Environ Sci Pollut Res Int 2021,28(41),58768-58780","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=70","first-page":"1","volume":"3","author":"Verma N.","year":"2017","unstructured":"Verma N.; Meena N.K.; Majumdar I.; Paul J.; Role of bromelain as herbal anti-inflammatory compound using in vitro and in vivo model of colitis. J Autoimmune Dis 2017,3,1-8","journal-title":"J Autoimmune Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.5530\/pj.2020.12.217","volume":"12","author":"Badriyya E.","year":"2020","unstructured":"Badriyya E.; Salman S.S.; Pratiwi A.R.; Dillasamola D.; Aldi Y.; Husni E.; Topical anti-inflammatory activity of bromelain. Pharmacogn J 2020,12(6s),1586-1593","journal-title":"Pharmacogn J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/plants10112273","volume":"10","author":"Pothacharoen P.","year":"2021","unstructured":"Pothacharoen P.; Chaiwongsa R.; Chanmee T.; Bromelain extract exerts antiarthritic effects via chondroprotection and the suppression of TNF-\u03b1\u2013induced NF-\u03baB and MAPK signaling. Plants 2021,10(11),2273","journal-title":"Plants"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"47306","DOI":"10.1007\/s11356-021-13803-y","volume":"28","author":"Majumder D.","year":"2021","unstructured":"Majumder D.; Debnath R.; Nath P.; Bromelain and Olea europaea (L.) leaf extract mediated alleviation of benzo(a)pyrene induced lung cancer through Nrf2 and NF\u03baB pathway. Environ Sci Pollut Res Int 2021,28(34),47306-47326","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.dscb.2021.100018","volume":"3","author":"Adu T.S.","year":"2021","unstructured":"Adu T.S.; Mabandla M.V.; Effects of bromelain on striatal neuroinflammation in rat model of Parkinsonism. Brain Disorders 2021,3,100018","journal-title":"Brain Disorders"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"lb256","DOI":"10.1096\/fj.201600240RR","volume":"30","author":"Hwang J.H.","year":"2016","unstructured":"Hwang J.H.; Koh E.J.; Lee Y.J.; Anti\u2010inflammatory effect of caffeine by regulating NF\u2010\u03baB activation in murine macrophage. FASEB J 2016,30,lb256","journal-title":"FASEB J"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.11637\/aba.2020.33.1.11","volume":"33","author":"Fan Y.J.","year":"2020","unstructured":"Fan Y.J.; Piao C.H.; Nguyen T.V.; Yu Z.N.; Chai O.H.; Song C.H.; Anti-allergic effects of caffeine in an allergic rhinitis mouse model. Anatomy Biol Anthropol 2020,33(1),11-19","journal-title":"Anatomy Biol Anthropol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/hel.12243","volume":"21","author":"Toyoda T.","year":"2016","unstructured":"Toyoda T.; Shi L.; Takasu S.; Anti\u2010inflammatory effects of capsaicin and piperine on Helicobacter pylori\u2010induced chronic gastritis in mongolian gerbils. Helicobacter 2016,21(2),131-142","journal-title":"Helicobacter"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10616-019-00338-x","volume":"71","author":"Vasanthkumar T.","year":"2019","unstructured":"Vasanthkumar T.; Hanumanthappa M.; Lakshminarayana R.; Curcumin and capsaicin modulates LPS induced expression of COX-2, IL-6 and TGF-\u03b2 in human peripheral blood mononuclear cells. Cytotechnology 2019,71(5),963-976","journal-title":"Cytotechnology"},{"key":"ref=79","first-page":"3029","volume":"11","author":"Zhang H.","year":"2019","unstructured":"Zhang H.; Bai Y.; Gao M.; Hepatoprotective effect of capsaicin against concanavalin A-induced hepatic injury via inhibiting oxidative stress and inflammation. Am J Transl Res 2019,11(5),3029-3038","journal-title":"Am J Transl Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/nu9060578","volume":"9","author":"Loganes C.","year":"2017","unstructured":"Loganes C.; Lega S.; Bramuzzo M.; Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage. Nutrients 2017,9(6),578","journal-title":"Nutrients"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1021\/acs.jafc.7b01792","volume":"65","author":"Yang H.","year":"2017","unstructured":"Yang H.; Du Z.; Wang W.; Structure\u2013activity relationship of curcumin: Role of the methoxy group in anti-inflammatory and anticolitis effects of curcumin. J Agric Food Chem 2017,65(22),4509-4515","journal-title":"J Agric Food Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s10753-018-0813-8","volume":"41","author":"Fouladi S.","year":"2018","unstructured":"Fouladi S.; Masjedi M.; Ghasemi R.G.; Hakemi M.; Eskandari N.; The in vitro impact of glycyrrhizic acid on CD4+ T lymphocytes through OX40 receptor in the patients with allergic rhinitis. Inflammation 2018,41(5),1690-1701","journal-title":"Inflammation"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fncel.2019.00319","volume":"13","author":"Kim G.H.","year":"2019","unstructured":"Kim G.H.; Paik S.S.; Park Y.S.; Kim H.G.; Kim I.B.; Amelioration of mouse retinal degeneration after blue LED exposure by glycyrrhizic acid-mediated inhibition of inflammation. Front Cell Neurosci 2019,13,319","journal-title":"Front Cell Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.intimp.2015.03.026","volume":"26","author":"Huang X.","year":"2015","unstructured":"Huang X.; Liu Y.; Lu Y.; Ma C.; Anti-inflammatory effects of eugenol on lipopolysaccharide-induced inflammatory reaction in acute lung injury via regulating inflammation and redox status. Int Immunopharmacol 2015,26(1),265-271","journal-title":"Int Immunopharmacol"},{"key":"ref=85","first-page":"lb339","volume":"31","author":"Lee A.","year":"2017","unstructured":"Lee A.; Yun J.M.; Hesperetin inhibits pro\u2010inflammatory cytokine secretion induced by lipopolysaccharide in differentiated human THP\u20101 monocytes under hyperglycemic conditions. FASEB J 2017,31,lb339","journal-title":"FASEB J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1039\/C4FO00606B","volume":"6","author":"Nidhi B.","year":"2015","unstructured":"Nidhi B.; Sharavana G.; Ramaprasad T.R.; Vallikannan B.; Lutein derived fragments exhibit higher antioxidant and anti-inflammatory properties than lutein in lipopolysaccharide induced inflammation in rats. Food Funct 2015,6(2),450-460","journal-title":"Food Funct"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.3892\/mmr.2017.7040","volume":"16","author":"Tan D.","year":"2017","unstructured":"Tan D.; Yu X.; Chen M.; Chen J.; Xu J.; Lutein protects against severe traumatic brain injury through anti-inflammation and antioxidative effects via ICAM-1\/Nrf-2. Mol Med Rep 2017,16(4),4235-4240","journal-title":"Mol Med Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.biopha.2017.05.103","volume":"92","author":"El-Kholy A.A.","year":"2017","unstructured":"El-Kholy A.A.; Elkablawy M.A.; El-Agamy D.S.; Lutein mitigates cyclophosphamide induced lung and liver injury via NF-\u03baB\/MAPK dependent mechanism. Biomed Pharmacother 2017,92,519-527","journal-title":"Biomed Pharmacother"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/antiox10030363","volume":"10","author":"Pap R.","year":"2021","unstructured":"Pap R.; Pandur E.; J\u00e1nosa G.; Sipos K.; Ag\u00f3cs A.; Deli J.; Lutein exerts antioxidant and anti-inflammatory effects and influences iron utilization of BV-2 microglia. Antioxidants 2021,10(3),363","journal-title":"Antioxidants"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Ou Y.; Hu G.; Naringenin attenuates non\u2010alcoholic fatty liver disease by down\u2010regulating the NLRP3\/NF\u2010\u03baB pathway in mice. Br J Pharmacol 2020,177(8),1806-1821","journal-title":"Br J Pharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/fsn3.2063","volume":"9","author":"Kataoka H.","year":"2021","unstructured":"Kataoka H.; Saeki A.; Hasebe A.; Shibata K.; Into T.; Naringenin suppresses toll\u2010like receptor 2\u2010mediated inflammatory responses through inhibition of receptor clustering on lipid rafts. Food Sci Nutr 2021,9(2),963-972","journal-title":"Food Sci Nutr"},{"key":"ref=92","first-page":"122","volume":"19","author":"Noori S.","year":"2020","unstructured":"Noori S.; Rezaei Tavirani M.; Deravi N.; Mahboobi Rabbani M.I.; Zarghi A.; Naringenin enhances the anti-cancer effect of cyclophosphamide against MDA-MB-231 breast cancer cells via targeting the STAT3 signaling pathway. Iran J Pharm Res 2020,19(3),122-133","journal-title":"Iran J Pharm Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/plants9040550","volume":"9","author":"Wali A.F.","year":"2020","unstructured":"Wali A.F.; Rashid S.; Rashid S.M.; Naringenin regulates doxorubicin-induced liver dysfunction: Impact on oxidative stress and inflammation. Plants 2020,9(4),550","journal-title":"Plants"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.abb.2015.08.008","volume":"583","author":"Gardi C.","year":"2015","unstructured":"Gardi C.; Bauerova K.; Stringa B.; Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Arch Biochem Biophys 2015,583,150-157","journal-title":"Arch Biochem Biophys"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2017.11.013","volume":"54","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Zhang X.; Xu M.; Wu X.; Zhao F.; Zhao C.; Quercetin attenuates collagen-induced arthritis by restoration of Th17\/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharmacol 2018,54,153-162","journal-title":"Int Immunopharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12272-017-0898-x","volume":"40","author":"Lee S.","year":"2017","unstructured":"Lee S.; Lee H.H.; Shin Y.S.; Kang H.; Cho H.; The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells. Arch Pharm Res 2017,40(5),623-630","journal-title":"Arch Pharm Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cyto.2019.01.001","volume":"116","author":"Cheng S.C.","year":"2019","unstructured":"Cheng S.C.; Wu Y.H.; Huang W.C.; Pang J.H.S.; Huang T.H.; Cheng C.Y.; Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-\u03b1-activated retinal pigment epithelial cells. Cytokine 2019,116,48-60","journal-title":"Cytokine"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.intimp.2014.12.035","volume":"24","author":"Cianciulli A.","year":"2015","unstructured":"Cianciulli A.; Dragone T.; Calvello R.; IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int Immunopharmacol 2015,24(2),369-376","journal-title":"Int Immunopharmacol"},{"key":"ref=99","first-page":"1269","volume":"17","author":"Zhou Z.X.","year":"2018","unstructured":"Zhou Z.X.; Mou S.F.; Chen X.Q.; Gong L.L.; Ge W.S.; Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF \u03baB in animal models of acute pharyngitis. Mol Med Rep 2018,17(1),1269-1274","journal-title":"Mol Med Rep"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.3390\/ijms22095006","volume":"22","year":"2021","unstructured":"Gruji\u0107-Milanovi\u0107 J, Ja\u0107evi\u0107 V, Miloradovi\u0107 Z, et al. Resveratrol protects cardiac tissue in experimental malignant hypertension due to antioxidant, anti-inflammatory, and anti-apoptotic properties. Int J Mol Sci 2021,22(9),5006"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5515396","volume":"2021","author":"Xing Z.","year":"2021","unstructured":"Xing Z.; He Q.; Xiong Y.; Zeng X.; Systematic pharmacology reveals the antioxidative stress and anti-inflammatory mechanisms of resveratrol intervention in myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med 2021,2021,1-15","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"10659","DOI":"10.18632\/aging.202830","volume":"13","author":"Zhang W.","year":"2021","unstructured":"Zhang W.; Yu H.; Lin Q.; Liu X.; Cheng Y.; Deng B.; Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway. Aging (Albany NY) 2021,13(7),10659-10671","journal-title":"Aging (Albany NY)"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intimp.2017.04.018","volume":"48","author":"Velagapudi R.","year":"2017","unstructured":"Velagapudi R.; Kumar A.; Bhatia H.S.; Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2\/ARE signalling. Int Immunopharmacol 2017,48,17-29","journal-title":"Int Immunopharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.1038\/s41598-021-95342-7","volume":"11","author":"Mohamed A.E.","year":"2021","unstructured":"Mohamed A.E.; El-Magd M.A.; El-Said K.S.; El-Sharnouby M.; Tousson E.M.; Salama A.F.; Potential therapeutic effect of thymoquinone and\/or bee pollen on fluvastatin-induced hepatitis in rats. Sci Rep 2021,11(1),15688","journal-title":"Sci Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6681729","volume":"2021","author":"Boskabady M.","year":"2021","unstructured":"Boskabady M.; Khazdair M.R.; Bargi R.; Thymoquinone ameliorates lung inflammation and pathological changes observed in lipopolysaccharide-induced lung injury. Evid Based Complement Alternat Med 2021,2021,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3839\/jabc.2018.006","volume":"61","author":"Kim A.H.","year":"2018","unstructured":"Kim A.H.; Jang J.H.; Woo K.W.; Chemical constituents of Dicentra spectabilis and their anti-inflammation effect. J Appl Biol Chem 2018,61(1),39-46","journal-title":"J Appl Biol Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"104016","DOI":"10.1016\/j.bioorg.2020.104016","volume":"101","author":"Yuan X.","year":"2020","unstructured":"Yuan X.; Han B.; Feng Z.M.; Jiang J.S.; Yang Y.N.; Zhang P.C.; Chemical constituents of Ligusticum chuanxiong and their anti-inflammation and hepatoprotective activities. Bioorg Chem 2020,101,104016","journal-title":"Bioorg Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/plants10061109","volume":"10","author":"Bajaj S.","year":"2021","unstructured":"Bajaj S.; Fuloria S.; Subramaniyan V.; Chemical characterization and anti-inflammatory activity of phytoconstituents from Swertia alata. Plants 2021,10(6),1109","journal-title":"Plants"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"e2100331","DOI":"10.1002\/cbdv.202100331","volume":"18","author":"Li R.","year":"2021","unstructured":"Li R.; Huang T.; Nie L.; Chemical constituents from staminate flowers of Eucommia ulmoides oliver and their anti\u2010inflammation activity in vitro. Chem Biodivers 2021,18(8),e2100331","journal-title":"Chem Biodivers"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"153684","DOI":"10.1016\/j.phymed.2021.153684","volume":"91","author":"Yang M.","year":"2021","unstructured":"Yang M.; Wang Y.; Fan Z.; Chemical constituents and anti-inflammatory activity of the total alkaloid extract from Melodinus cochinchinensis (Lour.) Merr. and its inhibition of the NF-\u03baB and MAPK signaling pathways. Phytomedicine 2021,91,153684","journal-title":"Phytomedicine"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jddst.2015.10.011","volume":"32","author":"Di Marzio L.","year":"2016","unstructured":"Di Marzio L.; Ventura C.A.; Cosco D.; Nanotherapeutics for anti-inflammatory delivery. J Drug Deliv Sci Technol 2016,32,174-191","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jiec.2017.02.021","volume":"51","author":"Kamalakannan R.","year":"2017","unstructured":"Kamalakannan R.; Mani G.; Muthusamy P.; Susaimanickam A.A.; Kim K.; Caffeine-loaded gold nanoparticles conjugated with PLA-PEG-PLA copolymer for in vitro cytotoxicity and anti-inflammatory activity. J Ind Eng Chem 2017,51,113-121","journal-title":"J Ind Eng Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7324\/JAPS.2018.81214","volume":"8","author":"Babu M.","year":"2018","unstructured":"Babu M.; Jerard C.; Michael B.P.; Suresh S.; Ramachandran R.; Mesoporous silica loaded caffeine inhibits inflammatory markers in lipopolysaccharide-activated rat macrophage cells. J Appl Pharm Sci 2018,8(12),124-131","journal-title":"J Appl Pharm Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7865024","volume":"2018","author":"Nitthikan N.","year":"2018","unstructured":"Nitthikan N.; Leelapornpisid P.; Natakankitkul S.; Improvement of stability and transdermal delivery of bioactive compounds in green robusta coffee beans extract loaded nanostructured lipid carriers. J Nanotechnol 2018,2018,1-12","journal-title":"J Nanotechnol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/molecules26051455","volume":"26","author":"Hudita A.","year":"2021","unstructured":"Hudita A.; Galateanu B.; Costache M.; In vitro cytotoxic protective effect of alginate-encapsulated capsaicin might improve skin side effects associated with the topical application of capsaicin. Molecules 2021,26(5),1455","journal-title":"Molecules"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jddst.2017.07.022","volume":"41","author":"Dewangan A.K.","year":"2017","unstructured":"Dewangan A.K.; Perumal Y.; Pavurala N.; Chopra K.; Mazumder S.; Preparation, characterization and anti-inflammatory effects of curcumin loaded carboxymethyl cellulose acetate butyrate nanoparticles on adjuvant induced arthritis in rats. J Drug Deliv Sci Technol 2017,41,269-279","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6655375","volume":"2021","author":"Le K.M.","year":"2021","unstructured":"Le K.M.; Trinh N.T.; Nguyen V.D.X.; Investigating the anti-inflammatory activity of curcumin-loaded silica-containing redox nanoparticles. J Nanomater 2021,2021,1-11","journal-title":"J Nanomater"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.3390\/ijms22115760","volume":"22","author":"Di Pompo G.D.","year":"2021","unstructured":"Di Pompo G.D.; Cortini M.; Palomba R.; Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed MSC in an in vitro model of osteosarcoma. Int J Mol Sci 2021,22(11),5760","journal-title":"Int J Mol Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2217\/nnm-2018-0415","volume":"14","author":"Zeeshan M.","year":"2019","unstructured":"Zeeshan M.; Ali H.; Khan S.; Mukhtar M.; Khan M.I.; Arshad M.; Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Nanomedicine (Lond) 2019,14(15),1945-1969","journal-title":"Nanomedicine (Lond)"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"28319","DOI":"10.1021\/acsomega.0c04300","volume":"5","author":"Mohanty S.","year":"2020","unstructured":"Mohanty S.; Sahoo A.K.; Konkimalla V.B.; Pal A.; Si S.C.; Naringin in combination with isothiocyanates as liposomal formulations potentiates the anti-inflammatory activity in different acute and chronic animal models of rheumatoid arthritis. ACS Omega 2020,5(43),28319-28332","journal-title":"ACS Omega"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"100605","DOI":"10.1016\/j.mtla.2020.100605","volume":"9","author":"Saha S.","year":"2020","unstructured":"Saha S.; Kundu J.; Verma R.J.; Chowdhury P.K.; Albumin coated polymer nanoparticles loaded with plant extract derived quercetin for modulation of inflammation. Materialia (Oxf) 2020,9,100605","journal-title":"Materialia (Oxf)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"173172","DOI":"10.1016\/j.ejphar.2020.173172","volume":"880","author":"Choudhary A.","year":"2020","unstructured":"Choudhary A.; Kant V.; Jangir B.L.; Joshi V.G.; Quercetin loaded chitosan tripolyphosphate nanoparticles accelerated cutaneous wound healing in Wistar rats. Eur J Pharmacol 2020,880,173172","journal-title":"Eur J Pharmacol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"120935","DOI":"10.1016\/j.ijpharm.2021.120935","volume":"606","author":"Diez-Echave P.","year":"2021","unstructured":"Diez-Echave P.; Ruiz-Malag\u00f3n A.J.; Molina-Tijeras J.A.; Silk fibroin nanoparticles enhance quercetin immunomodulatory properties in DSS-induced mouse colitis. Int J Pharm 2021,606,120935","journal-title":"Int J Pharm"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1021\/acs.molpharmaceut.7b00529","volume":"14","author":"Ju\u00e8re E.","year":"2017","unstructured":"Ju\u00e8re E.; Florek J.; Bouchoucha M.; In vitro dissolution, cellular membrane permeability, and anti-inflammatory response of resveratrol-encapsulated mesoporous silica nanoparticles. Mol Pharm 2017,14(12),4431-4441","journal-title":"Mol Pharm"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/biof.1611","volume":"46","author":"Sun L.","year":"2020","unstructured":"Sun L.; Hu Y.; Mishra A.; Protective role of poly(lactic\u2010co\u2010glycolic) acid nanoparticle loaded with resveratrol against isoproterenol\u2010induced myocardial infarction. Biofactors 2020,46(3),421-431","journal-title":"Biofactors"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1039\/D0FO00195C","volume":"11","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Liang X.; Zou Y.; Peng Y.; McClements D.J.; Hu K.; Resveratrol-loaded biopolymer core\u2013shell nanoparticles: Bioavailability and anti-inflammatory effects. Food Funct 2020,11(5),4014-4025","journal-title":"Food Funct"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.nano.2017.06.009","volume":"13","author":"Jain A.","year":"2017","unstructured":"Jain A.; Pooladanda V.; Bulbake U.; Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine 2017,13(7),2251-2262","journal-title":"Nanomedicine"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40139-021-00227-z","volume":"9","author":"Sharma S.","year":"2021","unstructured":"Sharma S.; Parveen R.; Chatterji B.P.; Toxicology of nanoparticles in drug delivery. Curr Pathobiol Rep 2021,9(4),133-144","journal-title":"Curr Pathobiol Rep"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1039\/C1CS15188F","volume":"41","author":"Sharifi S.","year":"2012","unstructured":"Sharifi S.; Behzadi S.; Laurent S.; Laird Forrest M.; Stroeve P.; Mahmoudi M.; Toxicity of nanomaterials. Chem Soc Rev 2012,41(6),2323-2343","journal-title":"Chem Soc Rev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jconrel.2019.06.008","volume":"304","author":"Allen C.","year":"2019","unstructured":"Allen C.; The question of toxicity of nanomaterials and nanoparticles. J Control Release 2019,304,288","journal-title":"J Control Release"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.lfs.2016.09.017","volume":"165","author":"Bostan H.B.","year":"2016","unstructured":"Bostan H.B.; Rezaee R.; Valokala M.G.; Cardiotoxicity of nano-particles. Life Sci 2016,165,91-99","journal-title":"Life Sci"},{"key":"ref=132","author":"Riego Sintes J.","unstructured":"Riego Sintes J.; Roebben G.; Linsinger T.;  European Commission, Joint Research Centre. An overview of concepts and terms used in the European Commission's definition of nanomaterial.Publications Office 2019. Available from:"},{"key":"ref=133","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/521014","author":"Khan H.A.","year":"2015","unstructured":"Khan H.A.; Shanker R.; Toxicity of nanomaterials. BioMed Research International 2015","journal-title":"BioMed Research International"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1007\/s10311-021-01280-1","volume":"19","author":"Patel G.","year":"2021","unstructured":"Patel G.; Patra C.; Srinivas S.P.; Kumawat M.; Navya P.N.; Daima H.K.; Methods to evaluate the toxicity of engineered nanomaterials for biomedical applications: A review. Environ Chem Lett 2021,19(6),4253-4274","journal-title":"Environ Chem Lett"}],"container-title":["Recent Advances in Inflammation &amp; Allergy Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2772270817666221027154402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210431\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2772270817666221027154402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:18:24Z","timestamp":1693570704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210431\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2772270817666221027154402","relation":{},"ISSN":["2772-2708"],"issn-type":[{"value":"2772-2708","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}